About United Health Products, Inc.United Health Products, Inc. (UEEC) develops, manufactures and markets products and technologies in the healthcare sector. UEEC's operating subsidiary Epic Wound Care, Inc. produces hemostatic gauze, derived from regenerated oxidized cellulose, which is all natural and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying emerging healthcare products and technologies for strategic partnership or acquisition. Safe Harbor Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.
United Health Products, Inc. (OTCQB: UEEC.PK) and its wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, today announced that Epic Wound Care's hemostatic gauze, which is registered and branded in the USA under the trademark HemoStyp™, has been featured in the Clinicians Report ® for the second time this year. The report is a published scientific testimonial that features products which have met the criteria and approval of the dental community. The Clinicians Report ® is a 35-year-old industry publication serving as an informative tool to the dental industry with distribution to over 10,000 dental care providers. It features new products with published test results that have been tested and approved by dentists and the dental community. In the December issue HemoStyp™ was listed among the "Best Products Evaluated During 2012" with 83% of the evaluators stating that they would recommend the product. Dr. Phillip Forman, CEO of United Health Products Inc., stated that the "continued recognition from the Clinicians Report ® validates the HemoStyp™ gauze and the use of the product in the dental industry." Dr. Forman went on to say that "as a result of the prior report the company has received an initial order from one of the dental industry’s largest dental products distributors" and believes that "this new report generates the same kind of interest in the product." The Clinicians Report ® December Edition can been viewed at the following link for a nominal fee – www.cliniciansreport.org/products/dental-reports. United Health Products, Inc. also announced the addition of Nate Knight to its Board of Directors. Mr. Knight brings to the company years of business experience and knowledge of the Company's HemoStyp™ product. Nate was a principal in Med Spring, Inc., the company that originally developed the HemoStyp™ gauze product, later acquired by United Health Products, Inc. Mr. Knight, age 64, has been a public accountant for over 30 years, has owned and operated his own accounting business, has previously held a Series 7 license, and is currently employed as an internal auditor with Prime Alliance Bank. Dr. Forman stated, "Mr. Knight, with his years of accounting experience and particular knowledge of the product as well as its potential applications, is a welcome addition to the Board of Directors."